Search Results for "Microangiopathic Ischemic"
Original Source: Genetic Variants in the C-Reactive Protein Gene Are Associated with Microangiopathic Ischemic Stroke.
Background and Purpose: C-reactive protein (CRP) is an independent risk factor for cardiovascular disease and ischemic stroke. CRP serum levels are influenced by genetic variation in the CRP gene. Studies investigating the relationship between ischemic stroke and polymorphisms in the CRP gene produced equivocal results. Here we investigate single-nucleotide polymorphisms (SNPs) in the CRP gene in a large German ischemic stroke sample. Methods: In a case-control design, 1,669 patients with ischemic stroke du...
Matching Channels
Matching News
Neuropeptide Biomarker Differentiates Ischemic Stroke
A biomarker of blood-brain barrier disruption may distinguish an ischemic stroke from a transient ischemic attack or an...
Cangrelor at PCI Cuts Ischemic Events vs Clopidogrel
Not yet approved by regulators anywhere, the novel P2Y12-receptor antagonist reduced the risk of 48-hour ischemic events compared with the older antiplatelet. Heartwire
New Ischemic Stroke Guidelines: The Nuts and Bolts
Dr. Mark Alberts dissects the new AHA/ASA guidelines for the early management of acute ischemic stroke. Medscape Neurology
ZZ Biotech and Laureate collaborate on ischemic stroke drug
Laureate Biopharma Services and ZZ Biotech teamed up on process development and manufacturing of ischemic stroke treatment 3K -More-
Silent infarcts prognostic in young stroke patients
Silent ischemic lesions are common and are associated with a high rate of recurrent events in young patients with acute ischemic stroke, report researchers.
Remote Assessment for IV Thrombolysis of Ischemic Stroke
Is remote telephone assessment effective in evaluating patients with acute ischemic stroke for IV thrombolytic therapy? Emergency Medicine Journal
New Guidelines for Controlling Stable Ischemic Heart Disease
Lifestyle changes and medical therapy should be the mainstay for most patients with stable ischemic heart disease, according to...
IST-3 Supports Wider Use of tPA in Ischemic Stroke Patients
Results from IST-3 show that IV tPA can be given safely in a wide variety of situations of acute ischemic stroke and benefits patients regardless of blood pressure, glucose, or stroke subtype. Medsc...
Matching PubMed Articles
Background and Purpose: C-reactive protein (CRP) is an independent risk factor for cardiovascular disease and ischemic stroke. CRP serum levels are influenced by genetic variation in the CRP gene. Stu...
INTRODUCTION: Malignancy is often associated with hematological disorders, but rarely is the diagnosis of malignancy secondary to the diagnosis of microangiopathic hemolytic anemia and thrombocytopeni...
Abstract This article reports a case of Goodpasture's syndrome and microangiopathic haemolytic anaemia developing in a patient with a 2-year history of systemic sclerosis. Goodpasture's syndrome usu...
Despite modern technological advancements in laboratory hematology, the blood film remains an important diagnostic aid. Herein, we report the case of a patient with a history of gastric cancer, who pr...
New insights in antiplatelet therapy for patients with ischemic stroke.
Acute treatment and long-term secondary prevention of noncardioembolic ischemic stroke and transient ischemic attack (TIA) include initiation of antiplatelet therapy. Antiplatelet agents currently use...
